Peter G. Shields

Affiliations: 
Georgetown University Medical Center, Washington, DC, United States 
Area:
Oncology, Molecular Biology, Epidemiology
Google:
"Peter Shields"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Singh A, Kinnebrew G, Hsu PC, et al. (2023) Untargeted Metabolomics and Body Mass in Adolescents: A Cross-Sectional and Longitudinal Analysis. Metabolites. 13
Shields PG, Song MA, Freudenheim JL, et al. (2020) Lipid laden macrophages and electronic cigarettes in healthy adults. Ebiomedicine. 60: 102982
Ganesan SM, Dabdoub SM, Nagaraja HN, et al. (2020) Adverse effects of electronic cigarettes on the disease-naive oral microbiome. Science Advances. 6: eaaz0108
Sharpnack MF, Cho JH, Johnson TS, et al. (2020) Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer. Lung Cancer (Amsterdam, Netherlands). 146: 36-41
Cheng G, Reisinger SA, Shields PG, et al. (2020) Quantitation by liquid chromatography-nanoelectrospray ionization-high resolution tandem mass spectrometry of DNA adducts derived from methyl glyoxal and carboxyethylating agents in leukocytes of smokers and non-smokers. Chemico-Biological Interactions. 109140
Gades MS, Petersen A, Meier E, et al. (2020) The role of subjective responses in electronic cigarette uptake and substitution in adult smokers. Drug and Alcohol Dependence. 107999
Gavrilin MA, McAndrew CC, Prather ER, et al. (2020) Inflammasome Adaptor ASC Is Highly Elevated in Lung Over Plasma and Relates to Inflammation and Lung Diffusion in the Absence of Speck Formation. Frontiers in Immunology. 11: 461
Crotty Alexander LE, Ware LB, Calfee CS, et al. (2020) NIH Workshop Report: E-cigarette or Vaping Product Use Associated Lung Injury (EVALI): Developing a Research Agenda. American Journal of Respiratory and Critical Care Medicine
Li M, Zhao S, Spakowicz D, et al. (2020) Neutrophil to lymphocyte ratio, PD-L1 expression, and survival in patients with advanced non-small cell lung cancer receiving first-line immune checkpoint inhibitor therapy. Journal of Clinical Oncology. 38: 46-46
Ying KL, Song M, Weng DY, et al. (2020) Abstract A34: Lung and salivary microbiome in electronic cigarette users, never-smokers, and smokers: A pilot cross-sectional study Cancer Research. 80
See more...